Will Tobacco Tax Affect Yield?

Tobacco companies will be hit with a new tax to help fund the NHS if Labour win at the next opposition, prompting concerns from income investors

Emma Wall 24 September, 2014 | 10:21AM
Facebook Twitter LinkedIn

Tobacco stocks will be hit with a new tax to fund the NHS if Labour wins the next election. The leader of the opposition Ed Milliband yesterday announced new plans to fund expansion to the National Health Service, starting with a £150 million tax on tobacco companies.

Imperial Tobacco (IMT) is the UK’s largest tobacco company and is expected to bear the brunt of the tax. Imperials director of corporate affairs Axel Gietz this morning called the tax unjust.

“Targeting one individual industry that happens to be unpopular with an additional tax is totally unwarranted and unjust and just a bad idea,” he said.

"If you look at the taxation level of tobacco products in this country we are at 86% of the price of a pack of cigarettes in this country.”

Gietz warned that if tobacco companies were forced to raise the price of cigarettes this could force consumers to buy dangerous illicit goods.

Despite the outrage, analysts are highlighting that £150 million is not a significant levy when compared to the revenues of these megacaps. Broker forecasts put pre-tax profits for Imperial for 2014 at £1.46 billion.

Will it Affect the Dividend?

Several of the largest and most successful UK equity income funds own tobacco stocks, including Neil Woodford in his Woodford Equity Income fund. British American Tobacco (BAT) is the third largest holding at 5.74% and Imperial makes up 5.72% of the fund.

This is because tobacco companies are among the highest yielding in the FTSE, with Imperial paying more than 4%.

Imperial also makes up 5% of Threadneedle UK Equity Alpha, 4.83% of Invesco Perpetual High Income and 4% of Fidelity Moneybuilder Dividend.

Woodford Funds has pressed to investors that tobacco companies remain an important part of their strategy and this potential measure does not affect their conviction in the sector.

Analyst’s View: Imperial’s Fair Value Would be Downgraded

Two new regulations proposed in the U.K. and France pose a threat to Big Tobacco profitability. Both are far from being implemented, however, and we are retaining our wide economic moat ratings and fair value estimates for the tobacco firms under our coverage until we see evidence of the probability of implementation growing, says Morningstar equity analyst Philip Gorham.

Imperial Tobacco would be the hardest hit by such a tax, and would contribute £60 million to £65 million per year, followed by Japan Tobacco with £57 million. We estimate that this would negatively impact our fair value estimate for Imperial by £7 per share, or 8%. The fair value estimate is currently £26.50, and the stock is trading at £26.90.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
British American Tobacco PLC2,549.00 GBP0.00Rating
CT UK Equity Alpha Inc Rtl Inc0.62 GBP-0.40Rating
Fidelity MoneyBuilder Dividend249.10 GBP0.08Rating
Imperial Brands PLC1,848.50 GBP0.00Rating
Invesco UK Eq High Inc UK Inc335.49 GBP-0.07Rating
LF Equity Income A Sterling Acc0.97 GBP0.00

About Author

Emma Wall  is former Senior International Editor for Morningstar

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures